Court Clarifies the Burden of Proof for Common General Knowledge and Admissibility of Supplementary Experimental Data

Supreme Administrative Court Invalidates Novartis's Crystalline Patent - Part I

Supreme Administrative Court Invalidates Novartis's Crystalline Patent - Part II

Judgment of Inventive Step for AI Invention Patents

Court Ruling on Patent Claim Interpretation

Pharmaceutical Patents: The Judicial Practice of the Supreme People's Court of China Regarding Supplementary Experimental Data

The Court Overturns CNIPA’s Determination on the Written Description Requirement for Parameter Limits

Amazon Alexa Trademark: Supreme Administrative Court Overturned IP Court’s Ruling on “Likelihood of Confusion”

How Global Retail Company TARGET Preserves Trademark Rights in Taiwan

Daniel Wellington Fights Against Squatters Part II: How Renowned Brands Protect its Trademark Before Registration

“MONSTER” is Common AND Distinctive: MONSTER STRIKE and MONSTER ENERGY are Confusingly Similar [Taiwan Supreme Administrative Court 2021 Decision]

Taiwan IP Court Clarifies Proof of Use in Trademark Non-use Cancellations: the IFIXIT CORPORATION Case

Confirming the Legitimacy of Parallel Imports of Genuine Goods - Analysis of Taiwan Supreme Court 2019 Taishangzi No. 397 Decision

Taiwan IP Court Rules on Parody and Trademark Infringement: LOUIS VUITTON MALLETIER v. LG HOUSEHOLD & HEALTH CARE

IP Court Overrules Decision of TIPO for Design Patent Obviousness

Taiwan Patent Act: Relaxation of Rules Regarding Grace Period

Expedited Examination of Design Patents in Taiwan Starts September 1, 2023

Taiwan IPO Launches Design Patent Electronic Priority Document Exchange (PDX) Program with KIPO from July 1, 2023

Key Considerations when Filing Multiple Design Patent Applications

Taiwan IPO Officially Accepts Electronic and Digital Signatures from 1 December 2022

Taiwan IPO Issues Electronic Patent and Trademark Certificates in 2023

Taiwan Sees Increasing Female Professionals in Intellectual Property

Executive Yuan passed draft amendment to Copyright Act on October 26

Strategies in response to the new Patent Examination Guidelines in Taiwan

The Taiwan Intellectual Property Office Limits the Allowability of Undisclosed Disclaimers in Patents

New Patent Linkage System in Taiwan: an effective solution to drug patent infringement disputes

Taiwan Patent Updates – Legislators Propose to Introduce Repair Clause for Motor Vehicle Parts in the Taiwan Patent Act

China Updates: Amendments to the China Patent Law will be Effective on 1 June 2021

Amendments to the Taiwan Patent Act will be effective on 1 November 2019

Non-obviousness and Infringement Judgment on Inventions with Parametric Claims: Analysis of Taiwan Intellectual Property Court Recent Decisions

Judgment of Inventive Step for AI Invention Patents

The Supreme People's Court of China’s Decision on the Requirements for Parameter Claims

IP Court Overrules Decision of TIPO for Design Patent Obviousness

Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, U.S. and Europe Practice: Part III

Different Decision on the Validity of DUPONT’s Patent in Taiwan and China- Taimide Tech. Inc. v DUPONT Electronics, Inc.

Taiwan IP Court on Teaching Away in Obviousness Determinations: Phoenix Silicon International Corporation v. Integrated Service Technology Inc.

Existence of a Motivation to Combine Prior Art References: Analysis of Taiwan Intellectual Property Court Decision on Patent Invalidation

Court Clarifies the Burden of Proof for Common General Knowledge and Admissibility of Supplementary Experimental Data

Supreme Administrative Court Invalidates Novartis's Crystalline Patent - Part I

Amazon Alexa Trademark: Supreme Administrative Court Overturned IP Court’s Ruling on “Likelihood of Confusion”

Supreme Administrative Court Invalidates Novartis's Crystalline Patent - Part II

Judgment of Inventive Step for AI Invention Patents

How Global Retail Company TARGET Preserves Trademark Rights in Taiwan

Daniel Wellington Fights Against Squatters Part II: How Renowned Brands Protect its Trademark Before Registration

Daniel Wellington Fights Against Squatters Part II: How Renowned Brands Protect its Trademark Before Registration

Recent trends in the similarity of goods between pet products and human products: Latest court decisions in Taiwan

Is using a trademarked common word infringing the owner's trademark rights? TutorABC wins case in Taiwan IP Court

Application Strategy of “Letter Trademark” – Analysis of the 2017 Taiwan Intellectual Property Court Decision

Is trademark "D&R" similar to trademarks "DIOR" and "廸奧"? The 2016 Taiwan Supreme Administrative Court Decision

“Reverse Confusion” in Taiwan – The Taiwan Supreme Administrative Court Finds it Violates First-to-file Principle (2016 Pan Zi Decision No. 465)

“Medical machines and apparatus”- Similarity of Goods: Japan Intellectual Property High Court: Administrative Litigation (2015 [Gyo-Ke] 10134)

Court Clarifies the Burden of Proof for Common General Knowledge and Admissibility of Supplementary Experimental Data

Supreme Administrative Court Invalidates Novartis's Crystalline Patent - Part I

Supreme Administrative Court Invalidates Novartis's Crystalline Patent - Part II

Case Study: How Examples Play a Decisive Role in Determining Inventive Step and Definiteness

Court Clarifies the Burden of Proof for Common General Knowledge and Admissibility of Supplementary Experimental Data

Supreme Administrative Court Invalidates Novartis's Crystalline Patent - Part I

Amazon Alexa Trademark: Supreme Administrative Court Overturned IP Court’s Ruling on “Likelihood of Confusion”

Supreme Administrative Court Invalidates Novartis's Crystalline Patent - Part II

Judgment of Inventive Step for AI Invention Patents

How Global Retail Company TARGET Preserves Trademark Rights in Taiwan

Daniel Wellington Fights Against Squatters Part II: How Renowned Brands Protect its Trademark Before Registration

Court Ruling on Patent Claim Interpretation

Pharmaceutical Patents: The Judicial Practice of the Supreme People's Court of China Regarding Supplementary Experimental Data

The Court Overturns CNIPA’s Determination on the Written Description Requirement for Parameter Limits

The Supreme People's Court of China’s Decision on the Requirements for Parameter Claims

Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, U.S. and Europe Practice: Part III

Different Decision on the Validity of DUPONT’s Patent in Taiwan and China- Taimide Tech. Inc. v DUPONT Electronics, Inc.

China Updates: Amendments to the China Patent Law will be Effective on 1 June 2021

Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, U.S. and Europe Practice: Part III

In-depth Guide of Eligibility Requirements for Biotech and Pharma Patents in the United States, Taiwan, Japan and China

Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, U.S. and Europe Practice: Part IV

Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, US and Europe Practice: Part II

Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, US and Europe Practice: Part I

Part III – How to Approach Non-Obviousness Requirement Examination for Chemical and Biopharma Patents in Europe, the United States, Taiwan, and China

Part II – How to Approach Non-Obviousness Requirement Examination for Chemical and Biopharma Patents in Europe, the United States, Taiwan, and China

“Medical machines and apparatus”- Similarity of Goods: Japan Intellectual Property High Court: Administrative Litigation (2015 [Gyo-Ke] 10134)

In-depth Guide of Eligibility Requirements for Biotech and Pharma Patents in the United States, Taiwan, Japan and China

Are trademarks with a “green outer ring” all Starbucks? An Analysis on Japan Intellectual Property High Court 2021 Gyo-Ke No. 10170 Judgement

(Continued) In-depth Guide of Eligibility Requirements for Biotech and Pharma Patents in the United States, Taiwan, Japan and China

The PPH Mottainai pilot program between Taiwan and Japan has been extended for three more years, starting from May 1, 2017

Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, U.S. and Europe Practice: Part III

Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, U.S. and Europe Practice: Part IV

Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, US and Europe Practice: Part II

Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, US and Europe Practice: Part I

Part III – How to Approach Non-Obviousness Requirement Examination for Chemical and Biopharma Patents in Europe, the United States, Taiwan, and China

Part II – How to Approach Non-Obviousness Requirement Examination for Chemical and Biopharma Patents in Europe, the United States, Taiwan, and China

Part I – How to Approach Non-Obviousness Requirement Examination for Chemical and Biopharma Patents in Europe, the United States, Taiwan, and China

“a2” Can be Registered on Milk Products: A Heated Debate on “Suggestive Trademark” and “Descriptive Trademark”

First Revision in 10 Years: Trademark Examination Guidelines on Distinctiveness & Key Points You Should Know

Are trademarks with a “green outer ring” all Starbucks? An Analysis on Japan Intellectual Property High Court 2021 Gyo-Ke No. 10170 Judgement

How Global Retail Company TARGET Preserves Trademark Rights in Taiwan

Taiwan IP Court Clarifies Proof of Use in Trademark Non-use Cancellations: the IFIXIT CORPORATION Case

Taiwan & China: Update practices in trademark non-use cancellation proceedings

“Medical machines and apparatus”- Similarity of Goods: Japan Intellectual Property High Court: Administrative Litigation (2015 [Gyo-Ke] 10134)

French Chocolatier Valrhona Successfully Overcomes Trademark Refusal: “ÉQUATORIALE” and “equator” are NOT Confusingly Similar

Key Amendments of Taiwan IPO New Examination Guidelines for Trademark Disclaimers

Non-use Cancellation: IP Court Confirmed After-sales Maintenance Services for Discontinued Products Cannot Be Used as Proof of Use

Court Clarifies the Burden of Proof for Common General Knowledge and Admissibility of Supplementary Experimental Data

Supreme Administrative Court Invalidates Novartis's Crystalline Patent - Part I

Supreme Administrative Court Invalidates Novartis's Crystalline Patent - Part II

The Supreme People's Court of China’s Decision on the Requirements for Parameter Claims

Different Decision on the Validity of DUPONT’s Patent in Taiwan and China- Taimide Tech. Inc. v DUPONT Electronics, Inc.

Taiwan & China: Update practices in trademark non-use cancellation proceedings

The Taiwan FTC Imposed Fines on Companies Advertising Products Marked with Revoked Patent Numbers

Daniel Wellington Fights Against Squatters Part II: How Renowned Brands Protect its Trademark Before Registration

Bypass indication-specific patent term extension to avoid pharma patent infringement --AstraZeneca AB v. TTY Biopharm Company Limited

Patentee has the Burden of Proof in Pharma Patent Infringement Case - Bayer Pharma AG v. Lotus Pharmaceutical Co.

New Patent Linkage System in Taiwan: an effective solution to drug patent infringement disputes

TFTC Deemed Issuance of Warning Letters During Patent Lapse Period Violates the Fair Trade Act

Case Study: How Examples Play a Decisive Role in Determining Inventive Step and Definiteness

Court Finds Prior Art Satisfying Existing Needs or High Cost of Improvement thereof does Not Determine Non-obviousness

Article “Analysis of Recent Judicial Trends in Key Patent Cases in Taiwan and China” was published in LES JAPAN NEWS, Vol. 65, No. 4, December 2024, issued by the Licensing Executives Society Japan.

Wisdom Ranked Silver in World Trademark Review WTR 1000 2025 Rankings

Wisdom was invited to contribute to the Taiwan Chapter of the Intellectual Property Law Over Borders Comparative Guide

Contribution to New Book “Infringement of Second Medical Use Claims”

Zoe Kwong from Wisdom Passed 2024 Taiwan Patent Bar Examination

“Navigating Inventiveness Assessment in Taiwan: Insights from Recent Court Decisions” Published by George Huang and Sandy Huang in GRUR International

World Trademark Review Recognizes Wisdom in WTR 1000 2024 Rankings

Taiwan Patent Practice Guide

Intellectual Property Law Over Borders Comparative Guide (December 2024)

Infringement of Second Medical Use Claims

GRUR International (September 2024)

FICPI Journal Issue 2 (July 2023)

AIPLA Innovate Magazine (June 2023)

JIPA’s Journal Article (May 2023) on Polymorph Patents and Patent Linkage Litigation

Infringement of Second Medical Use Claims

Taiwan Trademark Practice Guide

Taiwan Patent Practice Guide

Intellectual Property Law Over Borders Comparative Guide (December 2024)

GRUR International (September 2024)

FICPI Journal Issue 2 (July 2023)

AIPLA Innovate Magazine (June 2023)

Journal of Intellectual Property Management (Dec 2018, VOL.68 NO.12, NO.816)

JIPA’s Journal Article (May 2023) on Polymorph Patents and Patent Linkage Litigation

INTA Bulletin Vol. 77 Issue 30 (August 2022)